Pan genotypic response to combination treatment with Sofosbuvir and Daclatasvir in chronic Hepatitis C patients
Journal Title: International Journal of Biomedical Research - Year 2018, Vol 8, Issue 6
Abstract
Background and aims: Hepatitis C is a major cause of liver related morbidity and mortality. Prevalence of HCV infection in India has been variously estimated as 0.9 to 1.9%. With the advent of DAAs, the treatment has been revolutionized with more than 95% cure rate as observed in Caucasian population, while only scarce data on the same are available in the Indian population. Our study is aimed to assess the pan genotypic treatment response (SVR 12) to Sofosbuvir and Daclatasvir combination. Methods: Chronic hepatitis C patients who attended the department of gastroenterology in Calicut Medical College, Kerala, India were included in the study. All those patients with chronic hepatitis or compensated cirrhosis of liver received Sofosbuvir 400 mg and Daclatasvir 60 mg for 12 weeks and those with decompensated cirrhosis of liver received the both the drugs for 24 weeks. HCV RNA levels were measured at the beginning of the treatment, end of treatment and 12 weeks after completion of treatment. Results: 30 patients (22M: 8F) with a mean age of 478 years were included, of which 13 (43.3%) had cirrhosis of liver. Of the 13 Cirrhotic patients 9, 3, and 1 were in CTP A, B and C stage respectively. Among the total patients 23(76.7%), 5(16.7%), 2(6.7%) were genotype 3, 1 and 4 respectively .Three patients were treatment failure (previously treated with IFN and RBV combination), two were post renal transplant and one was a hemophilia patient. Median Viral load was: 499801 IU/ml (range: 2.4x10 3 -7.1x108), Median viral load in chronic hepatitis C patients and cirrhosis of liver patients were 2.8x106 and 1.3x106 IU/ml respectively. Overall ETR and SVR were 100% in patients across the genotype. No significant adverse reactions were observed. Conclusion: Combination treatment with Sofosbuvir and daclatasvir is very effective in chronic hepatitis patients with or without cirrhosis of liver, across the genotypes (Genotypes 1, 3 and 4)
Authors and Affiliations
Anup Sreedharan Nair, Thazhath Mavali Ramachandran, Prajob Prasad Geevarghese
Keywords
Related Articles
- EP ID EP452416
- DOI 10.7439/ijbr.v8i6.4220
- Views 130
- Downloads 0
Risk factors for ischaemic and intracerebral haemorrhagic stroke: A study from north eastern India
Background: Several risk factors like age, sex, hypertension, diabetes, hyperlipidaemia, smoking and alcohol intake have been previously been associated with stroke. However, differences have been postulated between the...
Epidemiological indicators of Cancer in North Saudi Arabia: A population-based Survey
Objective: The objective of the present study was to find out the approximateepidemiology of cancer burden in the adults' population of Hail region, North KSA. Methodology: A cross-sectional survey among 3326 Saudi civi...
Failures in Endosseous Dental Implants- A Literature review
Endosseous dental implants have become commonly used in clinical situations. Despite many advances in materials, techniques and implant design, the potential for clinical failure is a significant concern for both dentist...
Unusual Peritoneal Encapsulation: Case Report
Peritoneal encapsulation is an exceedingly rare developmental abnormality in which the small bowel is completely encased in an accessory peritoneal sac. Diagnosis is intraoperative as the clinical signs rarely help in di...
Evaluation of the outcome of single session Extracorporeal Shock Wave Lithotripsy for the treatment of renal stones - Initial experience at a tertiary care hospital
Aim: To determine the efficacy of Extracorporeal Shock Wave Lithotripsy (ESWL) in patients with renal stones and to investigate the role of ESWL in improving treatment outcomes. Methods: A total of 93 patients who under...